AO 1535

inhibits superoxide production by macrophages; putative anti-inflammatory agent

Also Known As:

3-Pyridinecarboxamide, N-(1-((beta-D-galactopyranosyloxy)methyl)-2-hydroxy-3-heptadecenyl)-, (R-(R*,S*-(E)))-; AO-1535

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Skin Diseases (Skin Disease) 07/01/1992 - "This study demonstrates that AO 1535 is able to inhibit the production of reactive oxygen intermediates in human monocytes and macrophages stimulated by phorbol ester and chemotactic tetrapeptide, suggesting a potential clinical application of AO 1535 in the treatment of inflammatory dermatoses."

1.	Reactive Oxygen Species (Oxygen Radicals)
2.	Phorbol Esters
3.	chemotactic tetrapeptide